Vivos Therapeutics Inc (VVOS) — Cash Flow-to-Debt Ratio
Vivos Therapeutics Inc (VVOS) has a Cash Flow-to-Debt Ratio of -0.23x as of March 2026, meaning its operating cash flow of $-6.01 Million could theoretically repay 0% of its total liabilities ($26.31 Million) in one year. Explore cash efficiency ratio of Vivos Therapeutics Inc to assess how effectively this company generates cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Vivos Therapeutics Inc Cash Flow-to-Debt Ratio (2018–2025)
Historical debt coverage capacity for Vivos Therapeutics Inc across 8 annual periods. Also explore VVOS asset base for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Vivos Therapeutics Inc (2018–2025)
Year-by-year debt coverage analysis for Vivos Therapeutics Inc. For market capitalisation and broader financial context, see how much is Vivos Therapeutics Inc worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.57x | $-15.26 Million | $26.70 Million | ▲ +67.0% |
| 2024 | -1.73x | $-12.69 Million | $7.33 Million | ▼ -49.6% |
| 2023 | -1.16x | $-11.95 Million | $10.32 Million | ▲ +47.3% |
| 2022 | -2.20x | $-19.59 Million | $8.92 Million | ▼ -13.7% |
| 2021 | -1.93x | $-15.73 Million | $8.15 Million | ▼ -185.9% |
| 2020 | -0.68x | $-5.68 Million | $8.41 Million | ▼ -32.7% |
| 2019 | -0.51x | $-5.34 Million | $10.49 Million | ▲ +67.7% |
| 2018 | -1.57x | $-5.31 Million | $3.38 Million | — |